Target intelligence / Profile preview

Bovine serum albumin subdomain IIA (BSA Subdomain IIA)

Target
BSA Subdomain IIA
Molecular classification
Transport protein [1], Serum albumin [1]
01

Overview

Bovine serum albumin (BSA) is a major plasma protein in cattle that serves as a primary carrier for a wide range of endogenous and exogenous ligands. Subdomain IIA, also known as Sudlow's site I or the warfarin binding site, is a prominent hydrophobic pocket within the protein structure that specifically binds bulky heterocyclic anions [2][4]. This subdomain is of significant interest in pharmacology because it is a major determinant of the pharmacokinetics of many drugs, influencing their distribution, metabolism, and excretion [3]. BSA is frequently used as a structural and functional model for human serum albumin (HSA) in drug-binding studies due to their high sequence homology and similar binding site architectures [4]. The interaction of drugs with subdomain IIA can lead to competitive displacement, which is a critical factor in understanding and predicting drug-drug interactions [2]. Furthermore, the presence of a single tryptophan residue (Trp-213) in this subdomain makes it a valuable tool for monitoring ligand binding through fluorescence spectroscopy [4]. References: [1] UniProt (P02769); [2] Sudlow et al. (1975) Mol Pharmacol 11(6):824-32; [3] Peters (1996) All About Albumin: Biochemistry, Genetics, and Medical Applications; [4] Majorek et al. (2012) Mol Immunol 52(3-4):174-82.

Other names
Sudlow's site IWarfarin binding siteBSA Site IDomain IIA of Bovine serum albumin
02

Mechanism of action

Drugs interact with subdomain IIA primarily through reversible binding within its large hydrophobic pocket, which serves to transport the drug through the circulatory system, protect it from rapid metabolism, and regulate its free concentration in the plasma [2][3].

03

Biological functions

Ligand transport [1][3]Maintenance of colloid osmotic pressure [3]pH buffering [3]Fatty acid binding [1]
04

Disease associations

Hypoalbuminemia [3]Drug toxicity due to altered binding capacity [2]
05

Safety considerations

Drug-drug interactions due to competitive displacement [2]Potential immunogenicity of bovine-derived proteins in humans [4]
06

Interacting drugs

Warfarin [2]

5 more in the full profile.

07

Biomarkers

Serum albumin concentration [3]

Beyond the preview

Go deeper on Bovine serum albumin subdomain IIA (BSA Subdomain IIA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovine serum albumin subdomain IIA (BSA Subdomain IIA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call